Bloomberg Markets & Finance via Youtube

Aug.05 — Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz sees a resilient value chain and strong growth from new products in the face of the Covid-19 pandemic. He speaks with Bloomberg’s Vonnie Quinn on “Bloomberg Markets.”

READ ALSO  SE: Ant’s Hong Kong Listing Wins China Approval